Compare FCN & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FCN | ITGR |
|---|---|---|
| Founded | 1982 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 4.3B |
| IPO Year | 1996 | 2000 |
| Metric | FCN | ITGR |
|---|---|---|
| Price | $151.70 | $126.50 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $165.00 | $91.14 |
| AVG Volume (30 Days) | 340.9K | ★ 784.0K |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 5.51 | N/A |
| EPS | ★ 3.89 | 1.17 |
| Revenue | ★ $3,788,857,000.00 | $1,853,637,000.00 |
| Revenue This Year | $7.39 | $1.69 |
| Revenue Next Year | $7.10 | $6.53 |
| P/E Ratio | ★ $39.47 | $107.18 |
| Revenue Growth | 2.44 | ★ 7.98 |
| 52 Week Low | $137.65 | $62.00 |
| 52 Week High | $189.30 | $126.14 |
| Indicator | FCN | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 49.81 | 79.42 |
| Support Level | $153.47 | $124.84 |
| Resistance Level | $157.23 | $126.14 |
| Average True Range (ATR) | 3.56 | 0.26 |
| MACD | 0.04 | -1.10 |
| Stochastic Oscillator | 55.15 | 85.61 |
FTI Consulting Inc is a firm that generates its sales by providing professional business advisory services to customers. The company operates through five segments, namely corporate finance, forensic and litigation consulting, economic consulting, technology, and strategic communications. The company generates the majority of its revenue from the Corporate finance segment. Customers of the company come from a wide array of sectors, including construction, energy and power, environmental, financial institutions, healthcare and life science, insurance, real estate and infrastructure, retail and consumer products, telecom, media, and technology. The majority of the company's revenue is derived from serving customers in the United States.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.